NEW YORK & CO INC (NWY) Fundamental Analysis & Valuation

Q: Can you provide the ChartMill fundamental rating for NEW YORK & CO INC?

ChartMill assigns a fundamental rating of 5 / 10 to NWY.

Q: Can you provide the profitability details for NEW YORK & CO INC?

NEW YORK & CO INC (NWY) has a profitability rating of 5 / 10.

Q: Can you provide the financial health for NWY stock?

The financial health rating of NEW YORK & CO INC (NWY) is 5 / 10.

NYSE:NWY • US6492951024

3.5

0 (0%)

At close: Nov 19, 2018

3.5

0 (0%)

After Hours: 11/19/2018, 8:04:04 PM

This NWY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

No Fundamental Analysis report for NWY not available.

NWY Fundamentals: All Metrics, Ratios and Statistics

NEW YORK & CO INC

NYSE:NWY (11/19/2018, 8:04:04 PM)

After market: 3.5 0 (0%)

3.5

0 (0%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Industry StrengthN/A

Industry GrowthN/A

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners41.45%

Inst Owner ChangeN/A

Ins Owners2.35%

Ins Owner Change0%

Market Cap226.91M

Revenue(TTM)928.09M

Net Income(TTM)11.25M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly Dividend0

Dividend Growth(5Y)0%

DP0%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	16.67
Fwd PE	11.67
P/S	0.24
P/FCF	N/A
P/OCF	N/A
P/B	2.57
P/tB	N/A
EV/EBITDA	3.91

EPS(TTM)0.21

EY6%

EPS(NY)0.3

Fwd EY8.57%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS14.32

BVpS1.36

TBVpSN/A

PEG (NY)0.17

PEG (5Y)0.42

Graham Number0 (-100%)

Profitability

		Industry Rank	Sector Rank
ROA	3.82%
ROE	12.76%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	1.31%
PM (TTM)	1.21%
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3Y0%

ROICexgc growth 5Y0%

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score8

Asset Turnover3.15

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.42
Quick Ratio	0.86
Altman-Z	3.76

F-Score8

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)155.56%

EPS 3YN/A

EPS 5Y39.33%

EPS Q2Q%0%

EPS Next Y100%

EPS Next 2Y73.21%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)1.52%

Revenue growth 3YN/A

Revenue growth 5Y-0.24%

Sales Q2Q%-3.46%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

NEW YORK & CO INC / NWY Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NEW YORK & CO INC?

ChartMill assigns a fundamental rating of 5 / 10 to NWY.

What is the valuation status for NWY stock?

ChartMill assigns a valuation rating of 4 / 10 to NEW YORK & CO INC (NWY). This can be considered as Fairly Valued.

Can you provide the profitability details for NEW YORK & CO INC?

NEW YORK & CO INC (NWY) has a profitability rating of 5 / 10.

Can you provide the financial health for NWY stock?

The financial health rating of NEW YORK & CO INC (NWY) is 5 / 10.

What is the expected EPS growth for NEW YORK & CO INC (NWY) stock?

The Earnings per Share (EPS) of NEW YORK & CO INC (NWY) is expected to grow by 100% in the next year.